Hepatorenal Syndrome

OVERVIEW

  • Hepatorenal Syndrome = profound oliguria and Na+ retention in the setting of severe liver dysfunction (cirrhosis or fulminant liver failure)
  • usually fatal unless liver transplant performed.
  • RRT can prevent advancement of condition

PATHOPHYSIOLOGY

  • ?
  • local production of intrarenal vasoconstrictors -> intrarenal vasoconstriction despite systemic vasodilation
  • increased Q with reduced SVR and MAP
  • hypovolaemia and raised intra-abdominal pressure may also be factors

Types

  • I – rapidly progressive

1. acute deterioration (doubling of creatinine or halving of CrCl over 2 weeks) 2. absent renal parenchymal disease 3. absent proteinuria 4. no shock 5. no history of nephrotoxic drugs

  • II – slower onset and progression

— renal failure in the context of end-stage liver disease that does not meet the criteria of type I

RISK FACTORS

  • Na+ and H2O retention (urinary Na+ < 5mEq/L and dilutional hyponatraemia)
  • low MAP
  • poor nutrition
  • reduced GFR
  • high plasma renin activity
  • oesophageal varices
  • associated with infection, acute alcohol hepatitis, large volume paracentesis without albumin replacement

INVESTIGATIONS

  • concentrated urine with low Na+ (<10mol/L)
  • few granular casts (doesn’t improve with fluid replacement)
  • no proteinuria
  • normal kidneys on U/S

DIAGNOSTIC CRITERIA

  • no other cause for renal failure
  • Na+ and H2O retention

Major

  • chronic or acute liver disease with advanced hepatic failure + portal hypertension
  • low GFR (Cr > 130mmol/L or CrCl < 40ml/min)
  • absence of shock, bacterial infection and recent treatment with nephrotoxic agents
  • no sustained improvement in renal function post 1.5 of isotonic saline
  • proteinuria < 0.5g/day
  • no renal tract disease on U/S

Additional

  • urine volume < 500mL/day
  • urine Na+ < 10mmol/L -urine osmolality > plasma osmolality
  • urine red blood count < 50 per high power field
  • serum Na+ < 130mmol/L

MANAGEMENT

  • diagnostic paracentesis (exclude SBP)
  • albumin
  • RRT
  • transjugular intrahepatic portosystemic shunt (TIPS) – reduces blood pressure in portal vein
  • liver dialysis (dialysis circuit with an albumin bound membrane to bind and remove toxins normally cleared by the liver)
  • IV clonidine (improves GFR)
  • terlipressin/octreotide – decrease portal vein pressure
  • liver transplant

CCC 700 6

Critical Care

Compendium

Chris is an Intensivist and ECMO specialist at The Alfred ICU, where he is Deputy Director (Education). He is a Clinical Adjunct Associate Professor at Monash University, the Lead for the  Clinician Educator Incubator programme, and a CICM First Part Examiner.

He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives. He was one of the founders of the FOAM movement (Free Open-Access Medical education) has been recognised for his contributions to education with awards from ANZICS, ANZAHPE, and ACEM.

His one great achievement is being the father of three amazing children.

On Bluesky, he is @precordialthump.bsky.social and on the site that Elon has screwed up, he is @precordialthump.

| INTENSIVE | RAGE | Resuscitology | SMACC

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.